Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA. Short-Term Cannabidiol with ?-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Mov Disord. 2024 May;39(5):863-875. PubMed PMID: 38487964
Domen CH, Sillau S, Liu Y, Leehey MA. Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds. Mov Disord. 2024 Jan;39(1):222-223. PubMed PMID: 38294047
Domen, C.H., Sillau, S. Liu, Y., Adkins, M., Rajkovic, S., Bainbridge, J., Sempio, C., Klawitter, J., & Leehey, M.A. (2023). Cognitive safety data from a randomized, double-blind, parallel-group, placebo-controlled phase IIb study of the effects of a cannabidiol and ?9-tetrahydrocannabinol drug on Parkinson disease-related motor symptoms. Movement Disorders, 38, 1341-1346. https://doi.org/10.1002/mds.29447
Holden, S.K., Domen, C.H., Sillau, S., Liu, Y., Leehey, M.A. (2022). Higher risk, higher reward? Self-reported effects of real-world cannabis use in Parkinson’s disease. Movement Disorders Clinical Practice, 9, 340-350. https://doi.org/10.1002/mdc3.13414
Domen CH, Collins RL, Davis JJ. The APPCN multisite didactic initiative: Development, benefits, and challenges. Clin Neuropsychol. 2021 Jan;35(1):115-132. PubMed PMID: 32615854
Domen CH, Greher MR, Hosokawa PW, Barnes SL, Hoyt BD, Wodushek TR. Are Established Embedded Performance Validity Test Cut-Offs Generalizable to Patients With Multiple Sclerosis?. Arch Clin Neuropsychol. 2020 Jul 24;35(5):511-516. PubMed PMID: 32186676
Wodushek TR, Domen CH. Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery. Appl Neuropsychol Adult. 2020 Jan-Feb;27(1):9-21. PubMed PMID: 30183361
Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. Mult Scler Relat Disord. 2019 Jan;27:383-390. PubMed PMID: 30502644
Domen CH, Shrestha A, Chapman K, Drees C. The impact of cannabis use on intracarotid amobarbital testing. Epilepsy Behav Rep. 2019;12:100328. PubMed PMID: 31497755